Could istaroxime be a lifeline for shock patients?
Disease control
Not yet recruiting
This trial tests the drug istaroxime in 600 adults with mild to moderate cardiogenic shock caused by acute heart failure. Participants receive a 48-hour IV infusion of istaroxime or a placebo, plus standard care. Researchers measure changes in blood pressure, breathing, and overa…
Phase: PHASE2, PHASE3 • Sponsor: Seismic Pharmaceuticals Operations LLC • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC